Recall Register

Drug recall: Paricalcitol Capsules, 1 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally…

Class III FDA enforcement event 72648. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

The recalling firm started this drug recall on 4 Nov 2015. The FDA record names a person as the firm, and this site does not show the name. The firm address in the FDA record is in Princeton, NJ. FDA put the recall in Class III. FDA event 72648 has 3 product records. The first FDA enforcement report date is 24 Feb 2016. The record gives the status Terminated, with the termination date 22 Jun 2017.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

The name is withheld, Princeton, NJ.

The FDA record gives the name of a person as the recalling firm. This site does not show the names of persons.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

3 product records in the event.

FDA event 72648: product records
Recall numberProductQuantityClassStatusReport date
D-0719-2016Paricalcitol Capsules, 1 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-663-309,155 bottlesClass IIITerminated24 Feb 2016
D-0720-2016Paricalcitol Capsules, 2 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-664-304383 bottlesClass IIITerminated24 Feb 2016
D-0721-2016Paricalcitol Capsules, 4 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-665-3011,123 bottlesClass IIITerminated24 Feb 2016

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2015
292
Share of these events in Class III
31%
Product records in this event
3

Official channels

Cite this page

Recall Register. FDA enforcement event 72648. https://recallregister.com/fda/iii/72648/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 72648?
The event has 3 product records. The first record gives this quantity: 9,155 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2015 have the same class?
31% of the 292 drug events that started in 2015 are in Class III.